CHICAGO, June 10, 2024 /PRNewswire/ — The Exosome Diagnostics and Therapeutics Market is projected to grow from USD 59 million in 2024 to USD 6,848 million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which…